CARE Announces Grant Awards to Recruit Researchers to Washington
The Andy Hill Cancer Research Endowment (CARE), a public-private partnership that supports cancer research in Washington, announced today its fourth round of grant awards totaling $1 million to leading research scientists with the aim of advancing cancer research in the state.
Individual grants of $500,000 were awarded to two new CARE Fund Distinguished Researchers, who were recruited by the Institute for Systems Biology and the Fred Hutchinson Cancer Research Center. Awardees include: Dr. Wei Wei an established scientist of high regard whose research holds high potential for strong workforce development opportunities and biotech advancements in Washington; and Dr. Lucas Sullivan, whose innovative research into the role of amino acid metabolism in cancer biology is of high significance. For more information, visit CARE’s grant awardees page.
The $1 million in awards of public funds to support recruitment and start-up packages for the CARE Fund Distinguished Researchers will be matched by more than $1.6 million in non-state funds committed by the host organizations. To date, a total of $5.65 million has been awarded for the recruitment of nine world-class cancer researchers and support of two research projects. Nearly $27 million has been committed by non-state resources to match state funding.
“The CARE Fund is pleased to support bringing these talented researchers to Washington. Each researcher builds additional investment in cancer research, carrying the promise of real progress toward improving health," said Eunice Hostetter, Secretary of the CARE Board and the Washington State Lead Ambassador for the American Cancer Society Cancer Action Network.
Grant applications for the recruitment of Distinguished Researchers were independently reviewed by the American Association for the Advancement of Science (AAAS). This cohort of Distinguished Researchers was recruited from the University of California, Los Angeles School of Medicine, and the Massachusetts Institute of Technology (MIT), Koch Institute for Integrative Cancer Research.